To determine the intracellular signaling mechanism of the 5-HT 2C receptor endogenously expressed in choroid plexus epithelial cells, we implemented a strategy of targeted disruption of protein-protein interactions. This strategy entails the delivery of conjugated membrane-permeable peptides that disrupt domain interaction at specific steps in the signaling cascade. As proof of concept, two peptides targeted against receptor-G protein interaction domains were examined. Only G q CT, which targets the receptor-G q protein interacting domain, disrupted 5-HT 2C receptor-mediated phosphatidylinositide hydrolysis. G s CT, targeting the receptor-G s protein, disrupted 2 adrenergic receptor-mediated activation of cAMP but not 5-HT 2C receptor-mediated phosphatidylinositide hydrolysis. The peptide MPS-PLC1M, mimicking the domain of phospholipase C1 (PLC1) interacting with active G␣ q , also blocked 5-HT 2C receptor activation. In contrast, peptides PLC2M and Phos that bind to and sequester free G␥ subunits were ineffective at blocking 5-HT 2C receptormediated phosphoinositol turnover. However, both peptides disrupted G␥-mediated ␣ 2A adrenergic receptor activation of mitogen-activated protein kinase. These results provide the first direct demonstration that active G␣ q subunits mediate endogenous 5-HT 2C receptor activation of PLC and that G␥ subunits released from G␣ q heterotrimeric proteins are not involved. Comparable results were obtained with metabotropic glutamate receptor 5 expressed in astrocytes. Thus, conjugated, membrane-permeable peptides are effective tools for the dissection of intracellular signals.The 5-HT 2 receptor family consists of three members, 5-HT 2A , 5-HT 2B , and 5-HT 2C . All three receptors belong to the G protein-coupled serpentine receptor superfamily. Their pharmacological profiles are very similar, leading to difficulty in defining their functional roles. 5-HT 2 receptors have been implicated in behaviors such as sleep, feeding, aggression, pain, and anxiety and are thought to play a role in a number of central nervous system disorders including affective disease, schizophrenia, and epilepsy (1). In addition, 5-HT 2 receptors may play a major role in mediating the actions of hallucinogenic drugs (2) as well as antipsychotic drugs (3, 4). Mice expressing nonfunctional 5-HT 2C receptors exhibit epileptic and obese phenotypes (5, 6), suggesting that these receptors play a crucial role in moderating central nervous system function.Expression of the 5-HT 2C receptor is exceptionally high in the choroid plexus (7,8), where it plays a role in the regulation of production and composition of cerebrospinal fluid (9 -11). Initial studies of 5-HT 2C receptor signaling showed that these receptors activate the downstream intracellular effector, phospholipase C (PLC) 1 resulting in the hydrolysis of phosphatidylinositol-4,5-bisphosphate into inositol-1,4,5-triphosphate and diacylglycerol (12). In addition, activation of the 5-HT 2C receptor has been observed to release arachidonic acid (13...